ACTRN12620000019909
Active, not recruiting
未知
A randomised-controlled trial of a parent-mediated intervention for optimising social and communication development of newborns at increased familial risk of autism spectrum disorders
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Autism Spectrum Disorder
- Sponsor
- Telethon Kids Institute
- Enrollment
- 130
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria for the trial are:
- •(a)Pregnant woman (eligible inclusion answer \= Yes)
- •(b)Carrying a singleton pregnancy (eligible inclusion answer \= Yes);
- •(c)Carrying a foetus with a relatively ‘high’ or ‘moderate’ likelihood of developing ASD based on the following criteria (eligible answer \= Yes):
- •High likelihood: The foetus has a biological mother, biological father, or full sibling with a clinical diagnosis of ASD. The diagnosis of the ‘proband’ (index case with the autism diagnosis) is confirmed by a copy of the diagnostic report.
- •Moderate likelihood: The foetus has a biological mother, biological father or full sibling with ADHD or intellectual disability (with no known cause), OR a biological grandparent, biological uncle/aunt, half sibling with autism. The diagnosis of the ‘proband’ (index case with the autism, ADHD or intellectual disability diagnosis) is confirmed by a copy of the diagnostic report.
- •(d)To the best of their knowledge, the primary carer and offspring are intending to remain in the Perth or Melbourne metropolitan area for the next two and a half years (eligible inclusion answer \= Yes); and
- •(e)English is the main language spoken at home (eligible inclusion answer \= Yes).
Exclusion Criteria
- •Exclusion criteria for the trial are:
- •(a)The foetus/offspring has been diagnosed with a serious medical condition requiring ongoing care, as determined by the study team (exclusion answer \= yes).
- •(b)The proband has a known genetic mutation associated with their clinical diagnosis (e.g., tuberous sclerosis complex, PTEN mutation etc.) that isn’t typically inherited (exclusion answer \= yes).
- •(c)The primary carer has a serious mental or physical health condition requiring ongoing care, as determined by the study team (exclusion answer \= yes).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Parent-mediated group-based therapy for young children diagnosed on the autism spectrum with worries about uncertainty or the unknowACTRN12621000294853Telethon Kids Institute64
Completed
Not Applicable
A family tobacco control program to reduce respiratory illness in Indigenous infants.ACTRN12609000937213Menzies School of Health Research420
Completed
Not Applicable
ew parent group intervention to Manage Repetitive Behaviours in young children with autism spectrum disorder (ASD)ISRCTN88687420orthumberland, Tyne and Wear NHS Foundation Trust (UK)36
Completed
Not Applicable
A cluster randomised controlled trial of maternal and child health handbook in MongoliaMaternal and Child HealthJPRN-UMIN000001748Osaka Medical Center and Research Institute for Maternal and Child Health, Japan500
Not yet recruiting
Not Applicable
To check the effect of intravenous dexmedetomidine versus dexmedetomidine in subarachnoid space on pain in patients undergoing surgery under spinal anaesthesia with heavy bupivacaineCTRI/2022/07/044353Department of anesthesiology Sawai Man Singh medical College and attached hospital